You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1076 to 1100 of about 5895
Next 25
05/19/2019
Latest ONC201 Clinical Efficacy to Be Presented in Oral Abstract Session at ASCO
Brain Tumor Awareness Month 2019 Webinar Series! Only 2 more webinars remaining this month!
05/17/2019
AbbVie brain cancer drug fails late-stage study in another oncology setback
05/16/2019
Optune Open Houses
05/15/2019
New edition of the "Brain Tumor Guide For The Newly Diagnosed" is now available!
05/14/2019
Study touts new method to reduce cognitive side effects of brain cancer radiation treatment
05/13/2019
BMS’ Opdivo fails late-stage brain cancer test
Brain Tumor Awareness Month 2019 Webinar Series! 2 more webinars in the next few days!
05/09/2019
New Treatment Could Become First Targeted Therapy Designed For ‘Untreatable’ Childhood Brain Cancer
Medicare proposal to cover Optune for Glioblastoma
Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System
The EndBrainCancer Initiative to Feature Renowned Brain Cancer and Modified Poliovirus Duke Researcher, Dr. Annick Desjardins, as its Keynote Speaker for the 2019 Annual May "Brains Matter" ACTION Dinner
Brain Tumor Awareness Month 2019 Webinar Series! 2 webinars in the next few days!
05/08/2019
Oncoceutics Invited to Present ONC201 at Public Advisory Committee Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee on June 20, 2019
05/05/2019
Reminder: Webinar tonight Sunday 5/5/19 7PM Eastern!
05/03/2019
Tmunity signs licensing deal for pediatric brain cancer immunotherapy
04/30/2019
Brain Tumor Awareness Month 2019 Webinar Series! (Schedule Change)
04/29/2019
Optune Open House
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
04/27/2019
Leptomeningeal metastases in glioma
Correlation of Tumor Treating Fields dosimetry to survival outcomes in newly diagnosed glioblastoma: A large-scale numerical simulation-based analysis of data from the Phase 3 EF-14 randomized trial.
National Walk To End Brain Tumors
04/20/2019
Cancer and the dopamine D2 receptor: a pharmacological perspective.